NeurogesX , Nasdaq: NGSX
Developing novel pain management therapies based on known chemical entities.
Industry: Health Care
First Day Return: -6.8%
NGSX
Developing novel pain management therapies based on known chemical entities.
| IPO Data | |
|---|---|
| IPO Date | 05/01/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $44 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | San Carlos, CA, United States |
| Founded | 1998 |
| Employees at IPO | n/a |
| Website www.neurogesx.com | |
IPO News for NeurogesX
NeurogesX (NGSX) Performance
